{"entity":{"type":"insider","cik":"0001653641","url":"/insider/0001653641","json_url":"/insider/0001653641.json","name":"Templeman Blaine","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":15,"first":"2017-01-13","last":"2020-09-17","span_basis":"filed_date"},"name_variants":[{"name":"Templeman Blaine","source":"filing","n_filings":15,"first_seen":"2017-01-13","last_seen":"2020-09-17"}],"transactions":[{"id":3342582,"accession":"0001567619-20-016853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-016853","line_url":"/filing/0001567619-20-016853#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12369.0,"shares_display":"12,369","price_per_share":2.3919,"price_display":"2.39","price_state":"stated","total_value":29585.4111,"total_display":"29,585.41","total_whole":"29,585","shares_owned_after":121916.0,"shares_owned_after_display":"121,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-17","scope":"insider"},{"id":2129838,"accession":"0001567619-20-014728","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-014728","line_url":"/filing/0001567619-20-014728#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7951.0,"shares_display":"7,951","price_per_share":2.5541,"price_display":"2.55","price_state":"stated","total_value":20307.6491,"total_display":"20,307.65","total_whole":"20,308","shares_owned_after":134285.0,"shares_owned_after_display":"134,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-07","filed_date":"2020-08-11","scope":"insider"},{"id":8290055,"accession":"0001567619-19-023145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-023145","line_url":"/filing/0001567619-19-023145#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1264.0,"shares_display":"1,264","price_per_share":1.1633,"price_display":"1.16","price_state":"stated","total_value":1470.4112,"total_display":"1,470.41","total_whole":"1,470","shares_owned_after":117736.0,"shares_owned_after_display":"117,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2019-12-16","scope":"insider"},{"id":7791479,"accession":"0001567619-19-018455","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-018455","line_url":"/filing/0001567619-19-018455","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12878.0,"shares_display":"12,878","price_per_share":1.3058457213853083,"price_display":"1.31","price_state":"stated","total_value":16816.6812,"total_display":"16,816.68","total_whole":"16,817","shares_owned_after":122888.0,"shares_owned_after_display":"122,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2019-09-17","scope":"insider","n_lines":2},{"id":6843026,"accession":"0001567619-18-008014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-008014","line_url":"/filing/0001567619-18-008014#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1241.0,"shares_display":"1,241","price_per_share":2.932,"price_display":"2.93","price_state":"stated","total_value":3638.612,"total_display":"3,638.61","total_whole":"3,639","shares_owned_after":129878.0,"shares_owned_after_display":"129,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-14","scope":"insider"},{"id":5988852,"accession":"0001567619-18-006813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-006813","line_url":"/filing/0001567619-18-006813#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":843.0,"shares_display":"843","price_per_share":2.9093,"price_display":"2.91","price_state":"stated","total_value":2452.5399,"total_display":"2,452.54","total_whole":"2,453","shares_owned_after":131119.0,"shares_owned_after_display":"131,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-20","filed_date":"2018-11-20","scope":"insider"},{"id":6102967,"accession":"0001567619-18-003109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-003109","line_url":"/filing/0001567619-18-003109#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10262.0,"shares_display":"10,262","price_per_share":5.8091,"price_display":"5.81","price_state":"stated","total_value":59612.9842,"total_display":"59,612.98","total_whole":"59,613","shares_owned_after":131119.0,"shares_owned_after_display":"131,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-24","filed_date":"2018-09-25","scope":"insider"},{"id":6505284,"accession":"0001567619-18-002684","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-002684","line_url":"/filing/0001567619-18-002684#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Executive VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6056.0,"shares_display":"6,056","price_per_share":6.4993,"price_display":"6.50","price_state":"stated","total_value":39359.7608,"total_display":"39,359.76","total_whole":"39,360","shares_owned_after":141381.0,"shares_owned_after_display":"141,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-13","filed_date":"2018-09-14","scope":"insider"},{"id":6849851,"accession":"0001140361-18-025010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-025010","line_url":"/filing/0001140361-18-025010#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":8.15,"price_display":"8.15","price_state":"stated","total_value":16300.0,"total_display":"16,300.00","total_whole":"16,300","shares_owned_after":69937.0,"shares_owned_after_display":"69,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-17","filed_date":"2018-05-21","scope":"insider"},{"id":5324462,"accession":"0001209191-17-066684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-066684","line_url":"/filing/0001209191-17-066684#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Executive VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2884.0,"shares_display":"2,884","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":23793.0,"total_display":"23,793.00","total_whole":"23,793","shares_owned_after":69937.0,"shares_owned_after_display":"69,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-18","filed_date":"2017-12-20","scope":"insider"},{"id":4950934,"accession":"0001209191-17-061614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-061614","line_url":"/filing/0001209191-17-061614#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Executive VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":243.0,"shares_display":"243","price_per_share":8.85,"price_display":"8.85","price_state":"stated","total_value":2150.55,"total_display":"2,150.55","total_whole":"2,151","shares_owned_after":58834.0,"shares_owned_after_display":"58,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-17","filed_date":"2017-11-17","scope":"insider"},{"id":5176613,"accession":"0001209191-17-053521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-053521","line_url":"/filing/0001209191-17-053521#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Executive VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2884.0,"shares_display":"2,884","price_per_share":11.2,"price_display":"11.20","price_state":"stated","total_value":32300.8,"total_display":"32,300.80","total_whole":"32,301","shares_owned_after":58834.0,"shares_owned_after_display":"58,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-18","filed_date":"2017-09-20","scope":"insider"},{"id":5282171,"accession":"0001209191-17-052891","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-052891","line_url":"/filing/0001209191-17-052891#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Executive VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3557.0,"shares_display":"3,557","price_per_share":10.9858,"price_display":"10.99","price_state":"stated","total_value":39076.4906,"total_display":"39,076.49","total_whole":"39,076","shares_owned_after":61718.0,"shares_owned_after_display":"61,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-13","filed_date":"2017-09-14","scope":"insider"},{"id":4082254,"accession":"0001209191-17-033760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033760","line_url":"/filing/0001209191-17-033760#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Executive VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1648.0,"shares_display":"1,648","price_per_share":9.65,"price_display":"9.65","price_state":"stated","total_value":15903.2,"total_display":"15,903.20","total_whole":"15,903","shares_owned_after":37300.0,"shares_owned_after_display":"37,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-17","filed_date":"2017-05-18","scope":"insider"},{"id":5250548,"accession":"0001209191-17-003674","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-003674","line_url":"/filing/0001209191-17-003674#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001653641","owner_name":"Templeman Blaine","owner_display_name":"Templeman Blaine","owner_url":"/insider/0001653641","role":"Officer (Executive VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3785.0,"shares_display":"3,785","price_per_share":11.95,"price_display":"11.95","price_state":"stated","total_value":45230.75,"total_display":"45,230.75","total_whole":"45,231","shares_owned_after":37300.0,"shares_owned_after_display":"37,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-11","filed_date":"2017-01-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001435049","name":"ADURO BIOTECH, INC.","url":"/issuer/0001435049","role":"Officer (Chief Legal Officer)","n_filings":15,"first_seen":"2017-01-13","last_seen":"2020-09-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001653641","retrieved_at":"2026-08-24T06:38:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}